Stay updated with breaking news from Eric Warren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Rating) has been assigned an average recommendation of “Hold” from the eleven brokerages that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and four have assigned a buy recommendation to the company. […]
UBS Group AG boosted its holdings in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Rating) by 66.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,461 shares of the biopharmaceutical company’s stock after acquiring an additional 9,377 shares during the […]
It won't feel like a resort or like you're roughing it, but it will definitely feel like you're having a Montana experience.
It won't feel like a resort or like you're roughing it, but it will definitely feel like you're having a Montana experience.
It won't feel like a resort or like you're roughing it, but it will definitely feel like you're having a Montana experience.